Hormone Replacement Therapy Latest Entry to AlzRisk Database
Despite almost two decades of research, it is not yet clear how hormone replacement therapy affects a woman’s risk of getting Alzheimer’s disease...
5721 RESULTS
Sort By:
Despite almost two decades of research, it is not yet clear how hormone replacement therapy affects a woman’s risk of getting Alzheimer’s disease...
An article in the February 24 Nature Neuroscience online suggests that amyloid-β (Aβ), the peptide responsible for the intercellular plaques that appear in the brains of Alzheimer's patients, can freely diffuse through neural tissue, and that it plays a major role in the pathogenesis of the disease...
A trio of collaborators has unearthed an unlikely regulator of α-synuclein gene (SNCA) expression...
Since Alois Alzheimer’s first descriptions of senile plaques, we have known that they are associated with dementia. But are they detrimental?...
In this week’s Nature, researchers report the first successful crystal structure of a bacterial presenilin homologue...
Amyloid plaques and tau tangles sprout in human neuron cultures grown in a supportive gel. Researchers think this system may closely model human disease and aid in drug discovery.
Mice expressing presenilin harboring AD-associated mutations resemble mice lacking the enzyme altogether, suggesting that the mutations fully inactivate the enzyme.
Levels of CSF biomarker neurogranin correlate with imaging measures of synaptic integrity in ADNI cohort.
Eli Lilly has given up on regulatory submission for mild AD, but leaves door open to seeking approval for earlier disease stages if three ongoing studies succeed.
Patients on solanezumab saw small improvements on multiple secondary endpoints.
Danish study correlates higher natural levels of lithium to lower incidence of Alzheimer’s disease
CryoEM reveals high-resolution view of full length of Aβ42 in a novel conformation.
Researchers claim that young cases of cerebral amyloid angiopathy may have been caused by contaminated surgical equipment.
Researchers from Spain describe changes in cannabinoid receptors in the brains of AD patients, as well as...
The material, previously used to treat children with growth deficiencies, triggered amyloid deposition in transgenic mice.